Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis

Neurobiology of Disease

Volumn 59, Issue , 2013, Pages 80-85

  Kim, Jean ^a   Kim, Tae Youn ^a   Cho, Kyung Sook ^a   Kim, Ha Na ^a   Koh, Jae Young ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

ALS; HSOD1; LC3; Spinal cord; Steroid hormone

Indexed keywords

3 METHYLADENINE; ADENINE; COPPER ZINC SUPEROXIDE DISMUTASE; GUANINE; MUTANT PROTEIN; PROGESTERONE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOPHAGY; DISEASE COURSE; DRUG MECHANISM; EXPLORATORY RESEARCH; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; IN VIVO STUDY; LIFESPAN; MALE; MOTONEURON; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL STIMULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SYMPTOM; TRANSGENIC MOUSE;

ALS; HSOD1; LC3; SPINAL CORD; STEROID HORMONE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; AUTOPHAGY; CELL COUNT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MOTOR NEURONS; NEUROPROTECTIVE AGENTS; PROGESTERONE; SPINAL CORD; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84881638591     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.07.011     Document Type: Article

References (49)

1. Abercrombie M. Estimation of nuclear population from microtome section. Anat. Rec. 1946, 94:239-247. (Feb).
2. Arciello M., Capo C.R., Cozzolino M., Ferri A., Nencini M., Carrì M.T., et al. Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide. J. Neurochem. 2010, 112(1):183-192. (Jan).
3. Beretta S., Sala G., Mattavelli L., Ceresa C., Casciati A., Ferri A., et al. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. Neurobiol. Dis. 2003, 13(3):213-221. (Aug).
4. Bjørkøy G., Lamark T., Pankiv S., Øvervatn A., Brech A., Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009, 452:181-197.
5. Bruijin L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998, 281(5384):1851-1854. (Sep).
6. Chen S., Zhang X., Song L., Le W. Autophagy dysregulation in amyotrophic lateral sclerosis. Brain Pathol. 2012, 22:110-116. (Jan).
7. Cutler S.M., Cekic M., Miller D.M., Wali B., Van Landingham J.W., Stein D.G. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 2007, 24:1475-1486. (Sep).
8. Deniselle M.C., Carreras M.C., Garay L., Gargiulo-Monachelli G., Meyer M., Poderoso J.J., et al. Progesterone prevents mitochondrial dysfunction in the spinal cord of wobbler mice. J. Neurochem. 2012, 122(1):185-195. (Jul).
9. Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B., et al. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(37):13860-13865. (Sep).
10. Fornai F., Longone P., Cafaro L., Kastsiuchenka O., Ferrucci M., Manca M.L., et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(6):2052-2057. (Feb).
11. Garay L., Deniselle M.C., Lima A., Roig P., De Nicola A.F. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid Biochem. Mol. Biol. 2007, 107:228-237.
12. Gonzalez Deniselle M.C., Lopez Costa J.J., Gonzalez S.L., Labombarda F., Garay L., Guennoun R., et al. Basis of progesterone protection in spinal cord neurodegeneration. J. Steroid Biochem. Mol. Biol. 2002, 83(1-5):199-209.
13. Harraz M.M., Marden J.J., Zhou W., Zhang Y., Williams A., Sharov V.S., et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Invest. 2008, 118(2):659-670. (Feb).
14. Irwin R.W., Yao J., Hamilton R.T., Cadenas E., Brinton R.D., Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008, 149(6):3167-3175. (Jun).
15. Ishrat T., Sayeed I., Atif F., Stein D.G. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res. 2009, 1257:94-101. (Feb).
16. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp. Neurol. 2010, 226(1):183-190. (Nov).
17. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 2012, 210:442-450. (May).
18. Kaur P., Jodhka P.K., Underwood W.A., Bowles C.A., de Fiebre N.C., de Fiebre C.M., et al. Progestrone increases brain-derived neurotrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J. Neurosci. Res. 2007, 85(11):2441-2449. (Aug).
19. Kikuchi H., Almer G., Yamashita S., Guégan C., Nagai M., Xu Z., et al. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(15):6025-6030. (Apr).
20. Kim J., Kim T.Y., Hwang J.J., Lee J.Y., Shin J.H., Gwag B.J., et al. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice. Neurobiol. Dis. 2009, 34(2):221-229. (May).
21. Kim H.N., Lee S.J., Koh J.Y. The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes. Neurochem. Int. 2012, 60(2):125-133. (Jan).
22. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 2007, 8(11):931-937. (Nov).
23. Koenig H., Schumacher M., Ferzaz B., Do Thi A.N., Ressouches A., Guennoun R., et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268(5216):1500-1503. (Jan).
24. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6(4):463-477. (Apr).
25. Li L., Zhang X., Le W. Altered macroautophagy in the spinal cord of SOD-1 mutant mice. Autophagy 2008, 4(3):290-293. (Apr).
26. Luoma J.I., Kelley B.G., Mermelstein P.G. Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity. Steroids 2011, 76(9):845-855. (Aug).
27. Maitra R., Reynolds J.N. Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms. Can. J. Physiol. Pharmacol. 1998, 76(9):909-920. (Sep).
28. Manjaly Z.R., Scott K.M., Abhinav K., Wijesekera L., Ganesalingam J., Goldstein L.H., et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph. Lateral Scler. 2010, 11(5):439-442. (Oct).
29. Menzies F.M., Cookson M.R., Taylor R.W., Turnbull D.M., Chrzanowska-Lightowlers Z.M., Dong L., et al. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 2002, 125(Pt 7):1522-1533. (Jul).
30. Meredith G.E., Totterdell S., Petroske E., Santa Cruz K., Callison R.C. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res. 2002, 956(1):156-165. (Nov).
31. Mizushima N., Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007, 3(6):542-545.
32. Morimoto N., Nagai M., Ohta Y., Miyazaki K., Kurata T., Morimoto M., et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007, 5(1167):112-117. (Sep).
33. Nixon R.A. Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 2007, 120(Pt23):4081-4091. (Dec).
34. Nixon R.A., Wegiel J., Kumar A., Yu W.H., Peterhoff C., Cataldo A., et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 2005, 64(2):113-122. (Feb).
35. Pizzasegola C., Caron I., Daleno C., Ronchi A., Minoia C., Carrì M.T., et al. Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph. Lateral Scler. 2009, 10(4):221-228. (Aug).
36. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., Scaravilli F., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36(6):585-595. (Jun).
37. Rubinsztein D.C., Cuervo A.M., Ravikumar B., Sarkar S., Korolchuk V., Kaushik S., et al. In search of an "autophagomometer". Autophagy 2009, 5(5):585-589. (Jul).
38. Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2011, 70(5):349-359. (May).
39. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog. Brain Res. 2009, 175:219-237.
40. Sayeed I., Parvez S., Wali B., Siemen D., Stein D.G. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res. 2009, 1263:165-173. (Mar).
41. Song C.Y., Guo J.F., Liu Y., Tang B.S. Autophagy and its comprehensive impact on ALS. Int. J. Neurosci. 2012, 122(12):695-703. (Dec).
42. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 2008, 57(2):386-397. (May).
43. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 1991, 37(2):173-182. (Apr).
44. Verstraete E., Veldink J.H., Huisman M.H., Draak T., Uijtendaal E.V., van der Kooi A.J., et al. Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial. J. Neurol. Neurosurg. Psychiatry 2012, 83(5):557-564. (May).
45. Wang I.F., Guo B.S., Liu Y.C., Wu C.C., Yang C.H., Tsai K.J., et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(37):15024-15029. (Sep).
46. Weydt P., Hong S.Y., Kliot M., Möller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003, 14(7):1051-1054. (May).
47. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49(4):391-402. (Apr).
48. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care 2008, 12(2):R61.
49. Zhang X., Li L., Chen S., Yang D., Wang Y., Zhang X., Wang Z., Le W. Rapamycin treatment augments motor neuron degeneration in SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 2011, 7(4):412-425. (Apr).